Moderna Inc MRNA

Healthcare Biotechnology

Moderna, Inc. is a biotechnology company. The Company is advancing a new class of medicines made of messenger ribonucleic acid (mRNA). It is developing therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases and autoimmune diseases, independently and with its strategic collaborators. mRNA medicines are designed to direct the body’s cells to produce intracellular, membrane or secreted proteins that have a therapeutic or preventive benefit with the potential to address a spectrum of diseases. Its diverse development pipeline consists of 45 therapeutic and vaccine programs, nine of which are in late-stage development. Its products include COVID-19 vaccines (mRNA-1273/Spikevax, next-generation mRNA-1283), RSV vaccine (mRNA-1345), Seasonal influenza vaccines (mRNA-1010, mRNA-1011, mRNA-1012, mRNA-1020 and mRNA-1030), Combination vaccines (mRNA-1083, mRNA-1230, mRNA-1045 and mRNA-1365), CMV vaccine (mRNA-1647), EBV vaccine (mRNA-1189 and mRNA-1195) and others.

NDAQ:MRNA - Post by User

Moderna Inc

<< Previous

Bullboard Posts

Next >>

Post by Dibah420on Nov 30, 2021 10:21am

115 Views

Post# 34179771

Good Riddance: zeropointIQ

After ingesting all that equine parasite purgative it seems the dunce has flushed himself down with the parasite.

Cheers

ps.
A few strategically oblique comments by Stephane Bancel have easily tumbled world wide markets.

https://www.aljazeera.com/economy/2021/11/30/moderna-ceos-comments-jolt-markets

<< Previous

Bullboard Posts

Next >>

Why invest?